Rajeev Chillakuru

Keine laufenden Positionen mehr

Health Technology

Distribution Services

Consumer Services

Ehemalige bekannte Positionen von Rajeev Chillakuru

Unternehmen	Position	Beginn	Ende
Virdante Pharmaceuticals, Inc. Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	12.05.2009	31.01.2012
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.	Corporate Officer/Principal	01.01.2004	01.01.2004
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	-	-
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

State University of New York at Buffalo

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	4
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
HALOZYME THERAPEUTICS, INC.	Health Technology

Private Unternehmen	3
Virdante Pharmaceuticals, Inc. Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA.	Distribution Services
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.	Health Technology